EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dysferlin and the Regulation of Ca2+ Release in Skeletal Muscle

Robert J Bloch iD, Joaquin Muriel, Valeriy Lukyanenko iD

Cells · 03.11.2025 · 14 (21) · 1724

DOI: 10.3390/cells14211724 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.11.2025. Verfasst von Robert J Bloch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, School of Medicine, University of Maryland, 655 W. Baltimore St., Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Calcium, Muscle, Skeletal, Dysferlin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 287 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Jain Foundation, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysferlin is a large transmembrane protein that is mutated or absent in Limb Girdle Muscular Dystrophy Type R2 (LGMD R2). Although it may have several functions in healthy skeletal muscle, most research on dysferlin has addressed its roles in repair of the sarcolemma and in maintaining proper control of Ca2+ homeostasis at the triad junction, where it concentrates. Here, we review the literature on the role of dysferlin in both membrane repair and in Ca2+ homeostasis, with a focus on the latter. We propose that pathophysiology in LGMD R2 is in part the result of increased leak of Ca2+ at the triad junction, which in turn reduces the amplitude of Ca2+ transients and, by activating Ca2+-induced Ca2+ release, or CICR, at the triad junction, induces Ca2+ waves. We discuss the mechanisms that regulate Ca2+ leak and Ca2+ levels at the triad junction under physiological and pathophysiological conditions. Our results suggest that suppression of abnormal leak and CICR may be therapeutic for LGMD R2 and other diseases of muscle linked to dysregulation of Ca2+ homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalciumMuscle, SkeletalDysferlinHumansAnimalsMuscular Dystrophies, Limb-GirdleCalcium SignalingHomeostasis

Stichwörter der Autor:innen

RyRcouplonexcitation-contraction couplingmembrane repairsarcolemma

Substanzen

CalciumDysferlin

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, School of Medicine, University of Maryland, 655 W. Baltimore St., Baltimore, MD 21201, USA.

ORCID-Profile: Robert J Bloch, Valeriy Lukyanenko

Förderung

  • NIAMS NIH HHS
  • Jain Foundation
  • NIH

Zitieren

APA

Bloch, R. J., Muriel, J., & Lukyanenko, V. (2025). Dysferlin and the Regulation of Ca2+ Release in Skeletal Muscle. Cells, 14(21), 1724. https://doi.org/10.3390/cells14211724

Vancouver

Bloch RJ, Muriel J, Lukyanenko V. Dysferlin and the Regulation of Ca2+ Release in Skeletal Muscle. Cells. 2025;14(21):1724. doi:10.3390/cells14211724

BibTeX
@article{Bloch2025,
  author = {Bloch, Robert J and Muriel, Joaquin and Lukyanenko, Valeriy},
  title = {Dysferlin and the Regulation of Ca2+ Release in Skeletal Muscle},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {21},
  pages = {1724},
  doi = {10.3390/cells14211724}
}
Kostenlos starten →